Similar trends were observed for t-tau and p-tau-181, which were positively associated with markers of cognitive impairment (e.g., CDRSB, ADAS-Cog13) and negatively associated with measures of preserved function (e.g., MMSE, RAVLT-immediate, WMS-delayed recall). The gene discussed is MAPT; the disease is Cognitive impairment.